Table 1.
Entry (Clinical Variables) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Gender Male/Female | Age (years) | Underlying liver disease (n) | Child classification (n) | Tumor distribution (n) | Tumor volume (cm3) | PVT (n = 31) | αFP level (kUI/l) (mean ± SD) | Platelet count (g/L) | Therapy prior RE |
Male = 66 | 67.9 ± 8.4 | Alcohol (31) | A5 (58) | Unifocal (44) | 198.2 ± 177.4 | Main (9) | 2669 ± 9529 | 173 ± 81 | No (65.7%) |
Female = 7 | HCV (7) | A6 (14) | Multifocal (29) | Branch + segmental (22) | Yes (34.3%)) | ||||
VBH (3) | B7 (1) | Surgery (4) | |||||||
Hemochromatosis (7) | Chemoembol. (16) | ||||||||
NASH (11) | Sorafenib (5) | ||||||||
NASH + Alcohol (10) | Radiofrequency (2) | ||||||||
Non-cirrhotic (4) |